SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Long-Term Antibiotic Use Affects ‘Good’ Gut Bacteria, Stanford University And University of Texas Southwestern Medical Center Studies
November 20, 2008
 · 
1 min read
Lone Star Bio
Protein Compels Ovarian Cancer Cells To Cannibalize Themselves, University of Texas MD Anderson Cancer Center Study
November 17, 2008
 · 
1 min read
Drug Development
Four Drug Combination Helps In Lung Cancer, University of Texas MD Anderson Cancer Center Study
November 14, 2008
 · 
1 min read
Drug Development
Hormone Creams Ease Menopause Symptoms, University of Texas Health Science Center Study
November 14, 2008
 · 
1 min read
Lone Star Bio
Taking Heart Medicine Beyond Heart Drugs
November 12, 2008
 · 
1 min read
Lone Star Bio
Protein Can Nurture Or Devastate Brain Cells, Depending On Its ‘Friends’, UT Southwestern Medical Center Studies
November 12, 2008
 · 
1 min read
Lone Star Bio
Genetics For Personalized Coronary Heart Disease Treatment, Baylor College of Medicine Study
November 12, 2008
 · 
1 min read
Lone Star Bio
Lack of Potassium Linked to High Blood Pressure, University of Texas MD Anderson Cancer Center Study
November 10, 2008
 · 
1 min read
Lone Star Bio
Genetic Predictors Of Esophageal Cancer Identified, University of Texas MD Anderson Cancer Center Study
November 5, 2008
 · 
1 min read
Lone Star Bio
Baylor College of Medicine Scientists Turbo-Charge Immune Cells To Fight Cancer
November 3, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Press Releases
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
January 13, 2026
 · 
10 min read
Load More